Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Walgreens (WBA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended February 2024.

Countdown to Walgreens (WBA) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Carnival

GameStop

The stock market will be closed on Good Friday. Plus, core PCE price index inflation data and earnings from GameStop, Carnival, and Walgreens Boots Alliance.

Walgreens, Carnival, GameStop and More to Watch This Week

Pfizer

After falling significantly, a pair of healthcare stocks offer above-average yields. New cancer drugs could lead to years of growth for Pfizer, but the pharma stock has been beaten down.

2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?

In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $20.58, denoting a -1.06% change from the preceding trading day.

Walgreens Boots Alliance (WBA) Declines More Than Market: Some Information for Investors

CNBC's Jim Cramer on Friday guided investors through next week's most important happenings on Wall Street.

Jim Cramer's week ahead: New consumer data and earnings from Walgreens

In the latest trading session, Walgreens Boots Alliance (WBA) closed at $20.80, marking a -1.38% move from the previous day.

Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: Here's Why

Walgreens Boots Alliance has opportunities to acquire Rite Aid stores and expand its geographic presence. Cost savings, deleveraging, lower interest rates and the opportunity to acquire some Rite Aid stores are strong catalysts. It is one of the best value plays on the market because some valuation metrics are at a 10-year low.

Walgreens: One Of The Best Value Picks At The Moment

Walgreens Boots Alliance, Inc. faces challenges in its retail pharmacy business due to lower demand for COVID-19 testing and tight prescription drug payouts. The company is transitioning into a healthcare powerhouse, investing in primary care practices and offering in-home health services. Despite declining earnings and cash flow, there is potential for a rebound as Walgreens stock is undervalued and sales are growing in the healthcare division.

Walgreens' Strategic Pivot

Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Walgreens Boots Alliance (WBA) Q2 Earnings Expected to Decline

Walgreens' (WBA) specialty pharmacy patients now have exclusive access to 240+ limited distribution drugs.

Walgreens' (WBA) AllianceRx Pharmacy Will Distribute VIVJOA

Cisco Systems

Intel

NextEra Energy

It operates through these segments: Client Computing Group Data Center Group Internet of Things Group Software and Services All Other segment The company's platforms are used in various computing applications comprising: Notebooks 2 1 systems Desktops Servers Tablets Smartphones Wireless and wired connectivity products Wearables Retail devices, and manufacturing devices, as well as for retail, transportation, industrial, buildings, home use, and other market segment Over two years ago, the company announced it would invest massively to build potentially the world's largest chip-making complex in Ohio.

5 Recently Beaten Down Dividend Stocks With Upside Potential

Diamondback Energy

Kraft Heinz

Walgreens has a 4.8% yield and just cut its dividend, a worrying sign for income investors. Kraft Heinz has a 4.6% yield and appears to be on the cusp of a business turnaround.

Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq-100?

AT&T

Dividend payments continue to be hugely important to investors, both as a source of income and as a means of growing their portfolios. And dividend payments are growing.

Capital Losses Ahead: Dump These 3 Dividend Stocks Now

Walgreens Boots Alliance chief executive officer Tim Wentworth is continuing his effort to turn around the drugstore chain by consolidating its massive distribution network.

Walgreens Consolidating Distribution In Latest Restructuring Move

Delta Air Lines

Ford Motor Company

General Motors

These 10 bargain-priced stocks can offer a margin of safety and provide nice appreciation potential if companies hit earnings estimates.

Delta Air Lines, Ford, GM, and Walgreens Are the Cheapest Stocks in the S&P 500

Sentiment surrounding Walgreens Boots Alliance has reached a negative extreme among both Main Street and Wall Street analysts. The stock's exit from the Dow may lead to temporary downsides, but long-term success depends on fundamentals and strategy. Despite the expected earnings drop in Q2, the stock's compressed P/E ratio and projected profit recovery make it an interesting investment opportunity.

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Amcor Plc

Franklin Resources

Chevron

Realty Income Corp

T. Rowe Price Group

In the middle of ongoing market uncertainty, a small subset of businesses is known as the Dividend Aristocrats, which have raised their dividends consistently, at least in the last 25 years. These companies continue to be solid, reliable, and growing.

Top 7 Dividend Aristocrats to Boost Your Portfolio's Earnings

Walgreens is adding Claire's products to its stores, a move that comes as pharmacy chains look to grow their relevance in consumers' day-to-day lives.

Walgreens Teams With Claire's as Pharmacies Aim to Be Consumers' One-Stop Shop

By the end of March, Claire's beloved products will be available in thousands of Walgreens  locations nationwide HOFFMAN ESTATES, Ill. , March 12, 2024 /PRNewswire/ -- Claire's Holdings LLC today announces a collaboration with integrated healthcare, pharmacy and retail leader Walgreens to bring the brand's assortment of fashion accessories and products to more than 4,400 Walgreens locations nationwide by the end of this month.

CLAIRE'S ANNOUNCES NATIONAL LAUNCH IN WALGREENS

Ulta Beauty

Organized retail crime rings can involve groups that sell stolen goods at flea markets and more sophisticated networks that resell stolen goods on Amazon.

Inside the organized crime rings plaguing retailers including Ulta, T.J. Maxx and Walgreens

Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs led to a nationwide shortage.

Walgreens settles New York charges it inflated prices of infant formula

Just because a stock's price fell does not mean it will stay down forever. Pfizer has a long roadmap for how to regain its recent glory.

1 Bruised Dividend Stock to Buy While It's Cheap, and 1 to Avoid

Apple

JPMorgan Chase & Co

Despite recent economic concerns, there are positive signs for the United States economy. These include declining inflation since mid-2023, a stable labor market with unemployment under 4% for two years, and ongoing record-setting stock market performance and infrastructure investments.

The Top 3 Retirement Stocks to Buy in March 2024

Walgreens Boots Alliance chief executive officer Tim Wentworth said the company won't sell its fast-growing Shields specialty pharmacy

Walgreens CEO: Shields Specialty Pharmacy Key To Growth And Won't Be Sold

Walgreens Boots Alliance, Inc. (NASDAQ:WBA ) 44th Annual TD Cowen Healthcare Conference March 4, 2024 9:10 AM ET Company Participants Tim Wentworth - CEO Manmohan Mahajan - CFO Conference Call Participants Charles Rhyee - TD Cowen Charles Rhyee And to start off one of the first sessions. I'm really pleased to have with us Walgreens and joining us is Tim Wentworth, newly appointed CEO; and Manmohan Mahajan, newly appointed full-time CFO.

News for Walgreens Stock (WBA)